Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Third Rock seeds a new approach to treating diabetes and obesity
Fierce Biotech
Monday, October 10, 2011 - 6:43pm
tags:
Third Rock, diabetes, obesity, Adipothermics
3 Companies Leading The Stem Cell Revolution
Seeking Alpha
Monday, October 10, 2011 - 6:40pm
tags:
stem cells, Geron, Neuralstem, Advanced Cell Technologies
Agony From Lipitor's Expiration Won't Be Exclusive To Pfizer
Seeking Alpha
Monday, October 10, 2011 - 6:37pm
tags:
Pfizer, generics, Lipitor, patents, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Merck
Pharmasset climbs after expanding study of hepatitis C drug for the second time
Yahoo/AP
Monday, October 10, 2011 - 6:35pm
tags:
Pharmasset, hepatitis C, PSI-7977
AstraZeneca earmarks $200M for Chinese plant
Fierce Pharma
Monday, October 10, 2011 - 12:13pm
tags:
China, AstraZeneca, drug manufacturing
Dynavax says data shows hepatitis B vaccine Heplisav works on patients who are hard to treat
Yahoo/AP
Monday, October 10, 2011 - 12:10pm
tags:
hepatitis B, Dynavax, Heplisav, GSK, Engerix-B
Novartis' Jimenez: Fix the Problem, and Not Just the Symptoms
NY Times, NY
Monday, October 10, 2011 - 12:08pm
tags:
Novartis, Joe Jimenez
California Gov Signs Controversial Vaccine Law
Pharmalot
Monday, October 10, 2011 - 12:06pm
tags:
vaccines, Merck, Gardasil, HPV, California, Cervarix, GSK
Dendreon's Provenge: Some On The Street Doth Protest Too Much
Seeking Alpha
Monday, October 10, 2011 - 12:02pm
tags:
Provenge, prostate cancer, Dendreon
Biotech Employment Grows Over 600% In California
Seeking Alpha
Monday, October 10, 2011 - 12:01pm
tags:
biotech, California, Amgen, Gilead, Medicis
FDA continues hold on Insmed drug trial in patients, asks for additional animal studies
Yahoo/AP
Monday, October 10, 2011 - 12:00pm
tags:
FDA, Insmed, Arikace, cystic fibrosis
Targacept launching new trial for Alzheimer's drug
Bizjournals.com
Monday, October 10, 2011 - 11:59am
tags:
Targacepts, Alzheimer's disease, AZD3480
Using Options In Speculative Biotech Investing
Seeking Alpha
Monday, October 10, 2011 - 11:26am
tags:
Antares Pharma, Aeterna Zentaris, options, Dendreon, BioSante, Keryx, Oncothyreon
Earnings Preview: Akamai, Advanced Micro Devices, Gilead Sciences, Biogen, Celgene
Seeking Alpha
Monday, October 10, 2011 - 11:18am
tags:
earnings, Gilead, Biogen Idec, Celgene
Senator Protests Agency Decision to Remove Doctor Data Online
NY Times, NY
Monday, October 10, 2011 - 11:05am
tags:
Charles Grassley, physician data
Stem-Cell Clinical Trials Move Debate Beyond Labs
WSJ Online
Monday, October 10, 2011 - 11:04am
tags:
stem cells, Pfizer, macular degeneration
Allos Therapeutics Falls After Counter-Offer Is Withdrawn
Bloomberg
Monday, October 10, 2011 - 11:01am
tags:
Allos, M&A, Amag Pharmaceuticals
Johnson & Johnson: Dividend Stock Analysis
Seeking Alpha
Monday, October 10, 2011 - 10:59am
tags:
JNJ, dividends
Inhibitex: Recent Price Action Sees Pressure To Cover Mounting
Seeking Alpha
Sunday, October 9, 2011 - 3:59pm
tags:
Inhibitex, herpes zoster, hepatitis C, S. aureus, Aurexis, INX-189
Real World Costs Impacting Dendreon's Provenge Sales
Seeking Alpha
Sunday, October 9, 2011 - 3:55pm
tags:
Dendreon, Provenge

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.